“…BMSCs secrete various soluble mediators, inhibit the proliferation and activation of various immune cells, and ultimately inhibit the activation of hepatic stellate cells. Research by Guo et al found that MSCs transplantation in patients with liver cirrhosis can inhibit the proliferation of peripheral blood T lymphocytes, upregulate the expression of CD4, CD25, and CD127, regulatory T cells (Treg), and also alleviate the Treg/Th17 imbalance [ 16 ]. Liu et al [ 17 ] also found that, during liver fibrosis, CD4+, CD25+, FoxD3, and other regulatory T cells in the liver increased, while NK cells decreased.…”